IDEAYA Biosciences Inc (IDYA)
42.18
+0.69
(+1.66%)
USD |
NASDAQ |
May 03, 16:00
42.16
-0.02
(-0.05%)
After-Hours: 20:00
IDEAYA Biosciences Market Cap: 3.145B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.145B |
| May 02, 2024 | 3.094B |
| May 01, 2024 | 3.070B |
| April 30, 2024 | 3.031B |
| April 29, 2024 | 3.031B |
| April 26, 2024 | 2.978B |
| April 25, 2024 | 2.880B |
| April 24, 2024 | 2.971B |
| April 23, 2024 | 2.909B |
| April 22, 2024 | 2.803B |
| April 19, 2024 | 2.768B |
| April 18, 2024 | 2.805B |
| April 17, 2024 | 2.995B |
| April 16, 2024 | 3.070B |
| April 15, 2024 | 3.095B |
| April 12, 2024 | 3.129B |
| April 11, 2024 | 3.240B |
| April 10, 2024 | 3.154B |
| April 09, 2024 | 3.174B |
| April 08, 2024 | 3.131B |
| April 05, 2024 | 3.170B |
| April 04, 2024 | 3.087B |
| April 03, 2024 | 3.143B |
| April 02, 2024 | 3.094B |
| April 01, 2024 | 3.170B |
| Date | Value |
|---|---|
| March 28, 2024 | 3.272B |
| March 27, 2024 | 3.229B |
| March 26, 2024 | 3.170B |
| March 25, 2024 | 3.155B |
| March 22, 2024 | 3.208B |
| March 21, 2024 | 3.402B |
| March 20, 2024 | 3.341B |
| March 19, 2024 | 3.304B |
| March 18, 2024 | 3.240B |
| March 15, 2024 | 3.303B |
| March 14, 2024 | 3.340B |
| March 13, 2024 | 3.408B |
| March 12, 2024 | 3.337B |
| March 11, 2024 | 3.249B |
| March 08, 2024 | 3.397B |
| March 07, 2024 | 3.372B |
| March 06, 2024 | 3.457B |
| March 05, 2024 | 3.343B |
| March 04, 2024 | 3.487B |
| March 01, 2024 | 3.446B |
| February 29, 2024 | 3.333B |
| February 28, 2024 | 3.323B |
| February 27, 2024 | 3.386B |
| February 26, 2024 | 3.443B |
| February 23, 2024 | 3.421B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
61.64M
Minimum
Mar 17 2020
3.514B
Maximum
Feb 16 2024
826.21M
Average
625.67M
Median
Market Cap Benchmarks
| Merck & Co Inc | 322.99B |
| Pfizer Inc | 157.48B |
| Geron Corp | 2.331B |
| Verastem Inc | 275.85M |
| Karyopharm Therapeutics Inc | 130.03M |
Market Cap Related Metrics
| PS Ratio | 103.70 |
| PEG Ratio | -0.5131 |
| Price to Book Value | 5.064 |
| Price | 42.18 |
| Earnings Yield | -4.67% |
| PEGY Ratio | -0.5131 |